Familial Hypertrophic Cardiomyopathy Latest Advances

Find the Latest Research About Familial Hypertrophic Cardiomyopathy

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1084 publications

Cas13-Mediated RNA Base Editing for the Treatment of Hereditary Hypertrophic Cardiomyopathy.

Cas13-Mediated RNA Base Editing for the Treatment of Hereditary Hypertrophic Cardiomyopathy.

Journal: Circulation
Published: May 18, 2026

Hypertrophic Cardiomyopathy in the Genomic Era: Genetic Testing Is No Longer Optional.

Hypertrophic Cardiomyopathy in the Genomic Era: Genetic Testing Is No Longer Optional.

Journal: JACC. Heart failure
Published: May 17, 2026

Genetic Testing in Hypertrophic Cardiomyopathy: Expanding Global Representation While Refining Interpretation.

Genetic Testing in Hypertrophic Cardiomyopathy: Expanding Global Representation While Refining Interpretation.

Journal: Arquivos brasileiros de cardiologia
Published: May 15, 2026

Molecular Stability as a Translational Gate: A Structured Framework for Target Validation in Genetic Cardiomyopathy.

Molecular Stability as a Translational Gate: A Structured Framework for Target Validation in Genetic Cardiomyopathy.

Journal: Cureus
Published: May 12, 2026

Therapeutic potential of ELABELA in alleviating hereditary hypertrophic cardiomyopathy.

Therapeutic potential of ELABELA in alleviating hereditary hypertrophic cardiomyopathy.

Journal: Journal of advanced research
Published: March 25, 2026

Hereditary Hemochromatosis and Hypertrophic Cardiomyopathy as Tier 1 Genomic Conditions: Implications for Adult Population Genomic Screening.

Hereditary Hemochromatosis and Hypertrophic Cardiomyopathy as Tier 1 Genomic Conditions: Implications for Adult Population Genomic Screening.

Journal: Public health genomics
Published: March 06, 2026

Mavacamten in Obstructive Hypertrophic Cardiomyopathy and C282Y Homozygous Hereditary Hemochromatosis: A First-in-Human Report.

Mavacamten in Obstructive Hypertrophic Cardiomyopathy and C282Y Homozygous Hereditary Hemochromatosis: A First-in-Human Report.

Journal: JACC. Case reports
Published: February 18, 2026

Evolution of Genetics, Genetic Testing, and Genotype Predictor Scores for Hypertrophic Cardiomyopathy: Phenotype Is Still King.

Evolution of Genetics, Genetic Testing, and Genotype Predictor Scores for Hypertrophic Cardiomyopathy: Phenotype Is Still King.

Journal: Journal of the American Heart Association
Published: February 12, 2026

Functional and Expression Studies of iPSC-Derived Cardiomyocytes Carrying a Novel HCM-Associated MYPN Genetic Variant.

Functional and Expression Studies of iPSC-Derived Cardiomyocytes Carrying a Novel HCM-Associated MYPN Genetic Variant.

Journal: Genes
Published: February 10, 2026

Leveraging the shared and opposing genetic mechanisms in the heritable cardiomyopathies.

Leveraging the shared and opposing genetic mechanisms in the heritable cardiomyopathies.

Journal: Research square
Published: February 06, 2026

Genetic re-analysis of a Chinese pedigree affected with Hypertrophic cardiomyopathy due to a heterozygous truncating variant of ALPK3 gene and literature review

Genetic re-analysis of a Chinese pedigree affected with Hypertrophic cardiomyopathy due to a heterozygous truncating variant of ALPK3 gene and literature review

Journal: Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
Published: February 06, 2026

Genetic diversity and molecular mechanisms in hypertrophic cardiomyopathy: toward personalized therapy.

Genetic diversity and molecular mechanisms in hypertrophic cardiomyopathy: toward personalized therapy.

Journal: American journal of physiology. Heart and circulatory physiology
Published: January 28, 2026
Showing 1-12 of 1,084

Last Updated: 06/30/2026